DECHECCHI, MARIACRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.144
EU - Europa 2.635
AS - Asia 1.912
SA - Sud America 252
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 31
OC - Oceania 5
Totale 8.026
Nazione #
US - Stati Uniti d'America 3.072
RU - Federazione Russa 1.025
SG - Singapore 700
CN - Cina 640
GB - Regno Unito 539
BR - Brasile 189
IT - Italia 175
HK - Hong Kong 172
SE - Svezia 170
FR - Francia 157
VN - Vietnam 141
FI - Finlandia 137
IE - Irlanda 137
DE - Germania 135
KR - Corea 80
BD - Bangladesh 37
CA - Canada 35
IN - India 28
NL - Olanda 27
UA - Ucraina 27
EC - Ecuador 21
IQ - Iraq 19
MX - Messico 19
AT - Austria 18
BE - Belgio 17
JP - Giappone 17
PL - Polonia 16
TR - Turchia 16
AR - Argentina 12
ID - Indonesia 12
NG - Nigeria 10
MA - Marocco 8
PK - Pakistan 8
ZA - Sudafrica 8
KZ - Kazakistan 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
CL - Cile 6
CZ - Repubblica Ceca 6
ES - Italia 6
JM - Giamaica 5
LV - Lettonia 5
NO - Norvegia 5
PE - Perù 5
PY - Paraguay 5
AU - Australia 4
AZ - Azerbaigian 4
CH - Svizzera 4
CO - Colombia 4
HU - Ungheria 4
IR - Iran 4
RO - Romania 4
TN - Tunisia 4
AL - Albania 3
GR - Grecia 3
NP - Nepal 3
PH - Filippine 3
PT - Portogallo 3
SN - Senegal 3
TG - Togo 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
VE - Venezuela 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BJ - Benin 1
BS - Bahamas 1
BT - Bhutan 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GH - Ghana 1
IL - Israele 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
MZ - Mozambico 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
RS - Serbia 1
Totale 7.996
Città #
Southend 429
Singapore 377
Moscow 356
Ashburn 326
Chandler 305
San Jose 281
Dallas 240
Woodbridge 211
Jacksonville 191
Hong Kong 171
Ann Arbor 140
Dublin 136
Beijing 135
Houston 129
Council Bluffs 126
New York 113
The Dalles 112
Verona 65
Los Angeles 63
Ho Chi Minh City 50
Jinan 48
Lawrence 47
Princeton 47
Wilmington 43
Helsinki 40
Munich 36
Nanjing 34
Hanoi 32
Santa Clara 32
Shenyang 32
Buffalo 30
Seoul 28
Sindelfingen 23
Columbus 21
Tianjin 21
São Paulo 19
Orem 18
Vienna 18
Brussels 17
Ningbo 16
Tokyo 16
Turku 16
Hebei 14
Kent 14
Lancaster 14
Montreal 14
Nanchang 14
Redondo Beach 14
Boardman 13
Changsha 13
Chennai 13
Guangzhou 13
Haikou 13
Hangzhou 13
Milan 13
Taizhou 13
Warsaw 13
Denver 12
Mexico City 12
Frankfurt am Main 11
Zhengzhou 11
Baghdad 10
Jiaxing 10
London 10
San Francisco 10
Amsterdam 9
Barnet 9
Chicago 9
Seattle 9
Stockholm 9
Boston 8
Redwood City 8
Rome 8
Taiyuan 8
Toronto 8
Abuja 7
Charlotte 7
Dearborn 7
Guayaquil 7
Haiphong 7
Da Nang 6
Dhaka 6
Jakarta 6
Lanzhou 6
Leiden 6
Manchester 6
Paris 6
Auburn Hills 5
Belo Horizonte 5
Biên Hòa 5
Brooklyn 5
Curitiba 5
Istanbul 5
La Paz 5
Norwalk 5
Quito 5
Rio de Janeiro 5
Atlanta 4
Baku 4
City of London 4
Totale 5.101
Nome #
Effetto anti-infiammatorio del miglustat su cellule dell'epitelio bronchiale 273
EFFETTO ANTI-INFIAMMATORIO DI TRIMETIL-ANGELICINA SU CELLULE DELL'EPITELIO BRONCHIALE 246
ANTI-INFLAMMATORY EFFECT OF MIGLUSTAT: SPHINGOLIPID METABOLISM AS A THERAPEUTIC TARGET FOR CF LUNG INFLAMMATION 229
Pharmacological modulators of sphingolipid metabolism for the treatment of cystic fibrosis lung inflammation 212
Effects of decoy molecules targeting NFkappaB transcription factors in Cystic fibrosis IB3-1 cells: Recruitment of NFkappaB to the IL-8 gene promoter and transcription of the IL-8 gene 206
PSEUDOMONAS AERUGINOSA MODULATES THE PHOSPHORYLATION CHANGES OF SCAFFOLDING PROTEINS AND APICAL EXPRESSION OF CFTR IN AIRWAYS 203
DOWN-MODULATION OF NEUTROPHIL CHEMOTACTIC SIGNALLING BY TARGETING THE METABOLISM OF SPHINGOLIPIDS 197
Effect of beta-Sitosterol in pro-inflammatory gene expression in bronchial epithelial cells 193
ANTI-INFLAMMATORY MOLECULES OBTAINED FROM VIRTUAL SCREENING OF A FUROCOUMARIN DATABASE AGAINST NF-KB 193
Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study 192
Chemical conjugation of ΔF508-CFTR corrector deoxyspergualin to transporter human serum albumin enhances its ability to rescue Cl- channel functions. 189
Modulators of Sphingolipid Metabolism Reduce Lung Inflammation 188
Docking of molecules identified in bioactive medicinal plants extracts into the p50 NF-kappaB transcription factor: correlation with inhibition of NF-kappaB/DNA interactions and inhibitory effects on IL-8 gene expression 179
COMBINED EFFECTS OF FUROCOUMARIN COMPOUNDS AS ANTI-INFLAMMATORY AND CFTR POTENTIATOR IN CALU-3 EPITHELIAL CELLS 178
Chloride conductance in membrane vesicles from human placenta using a fluorescent probe. Implications for cystic fibrosis 176
Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis 175
Anti-inflammatory effect of miglustat in bronchial epithelial cells 175
Geni modificatori del fenotipo polmonare in Fibrosi Cistica 174
Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells 171
Expression of microRNA-93 and Interleukin-8 during Pseudomonas aeruginosa-mediated induction of proinflammatory responses 169
Modulation of expression of genes involved in leukocyte chemotaxis by interfering with nuclear transcription factors 167
Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa. 166
BETA-SITOSTEROL, IDENTIFIED FROM NIGELLA ARVENSIS, INHIBITS THE INDUCTION OF IL-8 GENE IN BRONCHIAL EPITHELIAL CELLS 162
GBA2-Encoded β-Glucosidase Activity Is Involved in the Inflammatory Response to Pseudomonas aeruginosa 160
Transient Receptor Potential Ankyrin 1 Channels Modulate Inflammatory Response in Respiratory Cells from Patients with Cystic Fibrosis. 157
Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5 154
IMINOSUGAR-BASED INHIBITORS OF CERAMIDE GLUCOSYL-TRANSFERASE (GLCCERT) AND NONLYSOSOMAL GLUCOSYLCERAMIDASE (GBA2) REDUCE THE INFLAMMATORY RESPONSE TO P. AERUGINOSA IN CF BRONCHIAL EPITHELIAL CELLS 153
A peptide-nucleic acid targeting miR-335-5p enhances expression of cystic fibrosis transmembrane conductance regulator (CFTR) gene with the possible involvement of the CFTR scaffolding protein NHERF1 153
Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening 151
Circulating microRNAs as emerging non-invasive biomarkers for gliomas 149
GM1 as adjuvant of innovative therapies for cystic fibrosis disease 143
Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions 141
Protein kinase C activates chloride conductance in C127 cells stably expressing the cystic fibrosis gene 137
NIGELLA ARVENSIS EXTRACT INHIBITS THE INDUCTION OF IL-8 GENE IN BRONCHIAL EPITHELIAL CELLS 136
miRNAs in serum exosomes for differential diagnosis of brain metastases 134
Oxidative stress and antioxidant therapy in cystic fibrosis 127
Medicinal plant extracts inhibit the induction of pro-inflammatory genes in bronchial epithelial cells 125
PLCB3 in pro-inflammatory signaling in bronchial epithelial cells 125
Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis 122
TRIMETHYLANGELICIN MODULATES NEUTROPHIL CHEMOTAXIS IN MURINE MODEL OF PSEUDOMONAS AERUGINOSA ACUTE LUNG INFECTION 118
Miglustat and DGJ reduce the inflammatory response to pseudomonas aeruginosa, TNF-alpha and IL-1beta in bronchial epithelial cells 115
Silencing of genes coding for transcription factors: biological effects of decoy oligonucleotides on cystic fibrosis bronchial epithelial cells 114
Unravelling the role of sphingolipids in cystic fibrosis lung disease 112
Assessing the Potential of N-Butyl-l-deoxynojirimycin (l-NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent 111
Targeting transcription factor activity as a strategy to inhibit pro-inflammatory genes involved in cystic fibrosis: decoy oligonucleotides and low-molecular weight compounds 108
β-sitosterol ameliorates inflammation and Pseudomonas aeruginosa lung infection in a mouse model 106
Sphingolipids and plasma membrane hydrolases in human primary bronchial cells during differentiation and their altered patterns in cystic fibrosis 102
INVOLVEMENT OF THE CAAT/ENHANCER BINDING PROTEIN HOMOLOGOUS TRANSCRIPTION FACTOR (CHOP) IN P-AERUGINOSA-DEPENDENT IL-8 TRANSCRIPTION 99
LACK OF EFFICACY OF DEXAMETHASONE IN REDUCING THE INFLAMMATORY RESPONSE TO P. AERUGINOSA IN A CELL LINE DERIVED FROM BRONCHIAL EPITHELIUM OF A CF PATIENT 99
New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease 93
Molecular basis of cystic fibrosis: from bench to bedside 89
Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene 80
Totale 8.026
Categoria #
all - tutte 26.083
article - articoli 15.622
book - libri 0
conference - conferenze 8.676
curatela - curatele 0
other - altro 0
patent - brevetti 1.216
selected - selezionate 0
volume - volumi 569
Totale 52.166


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022230 0 0 3 15 17 14 6 23 20 13 31 88
2022/2023909 58 124 67 149 76 219 13 64 111 8 16 4
2023/2024506 24 36 29 60 49 117 7 31 0 34 101 18
2024/20251.018 50 57 34 192 30 39 73 43 157 56 96 191
2025/20263.370 222 166 249 511 845 247 330 155 295 195 68 87
2026/2027167 103 64 0 0 0 0 0 0 0 0 0 0
Totale 8.026